ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has filed with the U.S. Securities and Exchange Commission (SEC) a universal shelf registration statement which, when declared effective, will permit the company to issue up to an aggregate of $100 million of common stock, preferred stock, debt securities and warrants. Under this customary type of shelf registration, once effective, the company will have the flexibility to issue registered securities, from time to time, in one or more separate offerings or other transactions with the size, price and terms to be determined at the time of issuance. The registration statement also relates to the registration of 1,180,638 shares of common stock that the selling stockholders identified in the registration statement may sell from time to time.
